Nora D. Volkow, M.D.
Scientific Council Member (Joined 2001)
Nora D. Volkow, M.D.
Director, National Institute of Drug Abuse
Dr. Volkow pioneered the use of brain imaging to investigate the effects of drugs in the human brain and has demonstrated that drug addiction is a brain disease. She has documented a decrease in function of the dopamine system in addicted subjects and disruption in function of frontal brain regions involved in motivation and drive. Other areas of Dr. Volkow’s research include the neurochemical mechanisms responsible for variability in response to drugs among individuals; the rewarding and therapeutic effects of drugs; and changes in the dopamine system that occur with aging. She has shown that loss of dopamine brain function with age even in healthy subjects with no neurological dysfunction is associated with motor slowing and changes in cognitive task ability. She is currently focusing on strategies to minimize these losses.
Dr. Volkow was named one of Time magazine’s “Top 100 People Who Shape our World”, included as “One of the 20 People to Watch” by Newsweek magazine and named “Innovator of the Year” by U.S. News & World Report.
Meet the Scientist Webinar
Addiction as a Brain Disease: What Does it Mean?
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.